Colorectal Cancer

Improving proximal serrated polyp detection rate, along with adenoma detection rate, may increase colonoscopy effectiveness and reduce incidence of interval post-procedure colorectal cancer, according to new research.

Submitted medical claims and out-of-pocket costs for genetic counseling encounters appeared relatively low among patients with certain cancer types, according to a research letter published in JAMA Health Forum.

Individuals who increased alcohol consumption had higher risks for both alcohol-associated and all cancer types, according to results of a Korean population-based cohort study published in JAMA Network Open.

Although the number of Americans insured through Medicaid has increased during the past decade, barriers to cancer care access exist among Medicaid beneficiaries across high-quality centers, according to study results in JAMA Network Open.

For patients with unresectable colorectal cancer liver metastases and right-sided RAS or BRAF mutations, FOLFOXIRI plus bevacizumab vs. FOLFOX/FOLFIRI plus bevacizumab significantly increased PFS, according toASCO Annual Meeting results.

The FDA lifted its clinical hold on a trial designed to evaluate CYAD-101, an investigational chimeric antigen receptor T-cell therapy.

In this video, Smitha S. Krishnamurthi, MD, discussed the results of the IMPROVE trial, which she said showed significant results in terms of the length of PFS on treatment with an intermittent panitumumab plus FOLFIRI strategy.

In this video, Smitha S. Krishnamurthi, MD, discussed the results of the TRIPLETE trial, which she said showed no improvement when irinotecan was added to FOLFOX panitumumab in patients with mostly unresectable RAS and BRAF wild-type left-sided metastatic colorectal cancer.

Artificial intelligence-assisted colonoscopy improved overall adenoma detection rate compared with conventional colonoscopy, according to research published in Clinical Gastroenterology and Hepatology.

During the early months of the COVID-19 pandemic, the number of cancer screenings in the U.S. dropped sharply as states imposed stay-at-home orders and health care providers sought to reduce exposure to the virus and redeployed personnel.